UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.

UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients. Undersea Hyperb Med. 2020 Second Quarter;47(2):297-298 Authors: Abstract There have been numerous recent inquiries regarding use of hyperbaric oxygen (HBO2) for patients with COVID-19. Questions have been raised pertinent to two possible mechanisms for HBO2 in this clinical context. The UHMS Hyperbaric Oxygen Therapy Committee, UHMS Executive Committee, with collaborative input from multiple senior UHMS members and researchers have drafted this position statement. PMID: 32574446 [PubMed - in process]
Source: Undersea and Hyperbaric Medicine - Category: Sports Medicine Tags: Undersea Hyperb Med Source Type: research